Abiopharma

ResMed Inc. Daily Stock Update

New Form SCHEDULE 13G - 180 Life Sciences Corp. Filed: 2025-08-11 AccNo: 0001415889-25-021455 Size: 21 KB

New Form 4 - Enhabit, Inc. Filed: 2025-08-11 AccNo: 0002048471-25-000003 Size: 4 KB

New Form 4 - BridgeBio Pharma, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106751 Size: 15 KB

Body and Mind Inc. Announces Agreement to Divest San Diego Dispensary

New Form 4 - TANDEM DIABETES CARE INC Filed: 2025-08-11 AccNo: 0001438133-25-000165 Size: 5 KB

New Form 4 - BridgeBio Pharma, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106741 Size: 29 KB

New Form 4 - SI-BONE, Inc. Filed: 2025-08-11 AccNo: 0001562180-25-005706 Size: 6 KB

New Form 4 - IDEXX LABORATORIES INC /DE Filed: 2025-08-11 AccNo: 0000874716-25-000129 Size: 8 KB

New Form SCHEDULE 13G - Biomea Fusion, Inc. Filed: 2025-08-11 AccNo: 0001140361-25-030266 Size: 6 KB

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000096 Size: 7 KB

New Form 4 - ABBOTT LABORATORIES Filed: 2025-08-11 AccNo: 0001415889-25-021451 Size: 10 KB

Summit Plc - Prospectus filed pursuant to Rule 424(b)(5)

Alnylam präsentiert Fortschritte bei der Transformation der Behandlung von Herz-Kreislauf-Erkrankungen mit RNAi-Therapeutika auf dem Kongress der European Society of Cardiology 2025

New Form 4 - Jazz Pharmaceuticals plc Filed: 2025-08-11 AccNo: 0001765581-25-000094 Size: 6 KB